Both models argue that the stock will gravitate toward the €59.46 statutory squeeze-out anchor, viewing the current premium at €59.98 as unsustainable. They highlight deteriorating technicals, including falling volume and a MACD in contraction, alongside weak fundamentals such as a 31% drop in 2025 EBITDA and a €644 million net loss. GPT-5.4 notes that the €60.18-€60.20 resistance area will likely reject any breakout attempts as the delisting timetable into May caps upside potential.
All three models agree that 1COV is a short-horizon mean-reversion play, citing an oversold daily RSI near 30 and technical support at €59.30. The models emphasize that the €59.46 squeeze-out price provides a hard downside floor, limiting risk for a bounce toward the high-volume node at €60.18 or resistance at €60.20. Claude-Sonnet-4.6 specifically notes the stock is trading within its 30-day value area, suggesting a relief rally is plausible ahead of the May 5 delisting.
Covestro (1COV) is in the final stages of a forced delisting process, with the squeeze-out price set at €59.46 — just below the current market price of €59.98 — creating a hard ceiling on upside as arbitrageurs and remaining shareholders converge on the floor price. The stock is trading above the squeeze-out floor with falling volume (-79% vs prior 5-day average), deteriorating RSI on both the 4h (39.15) and daily (30.20) timeframes, and a MACD in contraction, suggesting the residual float is thinning out with sellers in control. With the AGM vote on May 19 and delisting on May 5, the risk/reward skews short as the stock gravitates toward the €59.46 squeeze-out anchor and weak 2025 fundamentals (EBITDA -31%, net loss €644M) provide no organic support.
With the squeeze-out price anchored at €59.46 and the current price at €59.98, the stock is trading in a narrow band just above the mandatory buyout floor — creating a technical support zone that limits downside for remaining minority shareholders. Daily RSI has reached 30.20 (oversold territory) while price sits above the €59.30 support level and within the 30-day value area (€59.42–€60.55) , suggesting a mean-reversion bounce toward the POC at €60.18 is plausible. A short-term relief rally toward resistance at €60.20 is the expected path, driven by the squeeze-out floor acting as a hard downside anchor ahead of the May 5 delisting.
Thesis Competition: BEAR case won (48% vs 41%).
This short is primarily an event-driven convergence trade rather than a broad macro bet: 1COV is still trading at €59.98, above the €59.46 statutory squeeze-out price, while the delisting/squeeze-out timetable into May should keep upside capped and pull the stock toward the compensation anchor. Technically, price is sitting just under the €60.18-€60.20 high-volume resistance area with falling daily RSI, fading 5-day volume, and weak relative performance versus the broader risk-on backdrop, which argues for rejection rather than breakout. With 2025 EBITDA down 31% and a €644 million net loss, the fundamentals do not justify a sustained premium above the cash-out level, so a fade back toward €59.46 is the cleaner path on this horizon.
This is a short-horizon mean-reversion long rather than a fundamental long-term bull call. 1COV is sitting just above a well-defined support shelf at €59.30 and close to the €59.46 squeeze-out price while daily RSI is near 30, so downside looks increasingly compressed even though the stock has lagged SPY and DBC for idiosyncratic corporate-action reasons. If support holds, the more likely path is a bounce back into the high-volume node near €60.18 and then toward €60.55 as low volatility, nearby event-price anchoring, and a bullish broader risk regime favor reversion over a fresh breakdown.
Thesis Competition: BEAR case won (57% vs 52%).
1COV is oversold with daily RSI at 30.20 near €59.30 support in a trending/bullish market regime. The squeeze-out arbitrage provides a floor at €59.46 while technical bounce potential offers upside to resistance at €60.20+. This is a mean reversion play with limited downside risk given the delisting floor.
1COV is approaching its May 5, 2026 delisting with a fixed squeeze-out price of €59.46, below the current €59.98. Weak fundamentals (EBITDA -31%, net loss €644M) and sector headwinds from German industrial stagflation should drive the stock toward the squeeze-out level as the AGM vote on May 19 approaches, creating a mean reversion setup with limited upside.
Thesis Competition: BULL case won (51% vs 47%).